Sponsors (3)
The bill aims to make coverage more affordable and increase antitrust enforcement to lower prices and expand access, but it raises federal spending, creates market shifts that could disrupt private coverage and provider participation, and leaves implementation and enforcement details that create legal and administrative uncertainty.
Middle‑income families, lower‑income shoppers, and uninsured people would likely see lower Marketplace premiums and greater affordability because national risk‑pooling/reinsurance and changes to premium tax credit rules (including fixing the 'family glitch' and removing the 400% FPL cap) spread high‑cost risk and expand subsidies.
Patients relying on Medicare Exchange coverage would face stronger protections against provider‑imposed acceptance restrictions and nondiscrimination, improving their access to care in federally supported programs.
Consumers and patients (including Medicaid and Medicare beneficiaries) could benefit from lower prices and more competition if increased DOJ and FTC antitrust funding leads to more enforcement against anticompetitive conduct in provider and drug markets.
Taxpayers and federal finances face materially higher federal spending and potential deficit pressure because the bill expands subsidies, funds reinsurance/antitrust enforcement, and removes some cost‑containment mechanisms.
Medicare beneficiaries and patients with chronic or specialty drug needs could pay higher drug prices or miss out on lower negotiated prices because the bill removes or limits Medicare drug negotiation authorities.
Private insurers, employer plans, and some consumers could face market disruption (plan exits, changed offerings, or premium shifts) as public plan expansion, national pooling, and altered subsidy rules change incentives and risk distribution in insurance markets.
Based on analysis of 8 sections of legislative text.
Creates a Medicare‑style public plan, expands and redesigns ACA premium tax credits, funds reinsurance, removes a Medicare drug negotiation subsection, and boosts antitrust enforcement funding.
Official title: To establish a public health plan.
Introduced July 15, 2026 by Angela Craig · Last progress July 15, 2026
Creates a Medicare‑style public health plan and changes the Affordable Care Act tax credit and market rules to lower premiums and expand affordability. It also funds a national reinsurance program, restricts provider exclusion practices that limit plan access, removes a Medicare drug negotiation provision, and invests in antitrust study and enforcement for health care markets. Major changes include establishing a new public plan under the Social Security Act, expanding and redesigning premium tax credits (with a removal of the explicit 400% cap and a linear applicable percentage schedule), authorizing multiyear reinsurance funding, deleting current Medicare drug price negotiation subsection, and providing multi‑year appropriations to DOJ and FTC for health care antitrust work with required reports to Congress.